Catalyst Wire Dossier Catalyst Wire Dossier

Brexpiprazole long-acting injection

brexpiprazole · Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Brexpiprazole long-acting injection, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: The Purpose of This Study is to Determine the Safety, Tolerability, and Pharmacokinetics of Brexpiprazole Long-acting Injection Following a Single Administration in Healthy Subjects/Patients With Schizophrenia. [Phase 1]

See pricing